KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early ...

The research team led by Professor Kwang-Hyun Cho of KAIST Bio and Brain Engineering who recently announce "Cancer Reversion ...

A generative AI-based technique can predict thousands of 3D genomic structures in just minutes, enabling researchers to more ...

A critical transition is a phenomenon in which a sudden change in state occurs at a specific point in time, like water ...

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

A novel, freely available AI tool has cut the time it takes to determine chromatin structure from days to minutes. The 3D ...

EMA's CHMP has recommended AstraZeneca's Imfinzi for approval in the EU as a single agent for limited-stage small cell lung ...